Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-03-13
2000-02-01
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540552, A61K 3155, C07D28110, C07D41712
Patent
active
060203307
ABSTRACT:
The present invention is concerned with new hypolipidemic compounds, with processes and novel intermediates for their preparation, with pharmaceutical compositions containing them and with their use in medicine, particularly in the prophylaxis and treatment of hyperlipidemic conditions, such as atherosclerosis.
Compounds of the formula (I): ##STR1## wherein R.sup.1 to R.sup.10 and X are a defined in the specification and are useful as hypolipidemic compounds.
REFERENCES:
patent: 5580866 (1996-12-01), Housley et al.
patent: 5663165 (1997-09-01), Brieady
patent: 5723458 (1998-03-01), Brieaddy et al.
Grundy, "Cholesterol and Coronary Heart Disease", JAMA, vol. 256, No. 20, pp. 2849-2858, Nov. 28, 1986.
P. Tyle, Review, "Iontophoretic Devices for Drug Delivery", Pharmaceutical Research, vol. 3, No. 6, pp. 318-326, 1986.
Enhsen Alfons
Falk Eugen
Glombik Heiner
Stengelin Siegfried
Hoechst Aktiengesellschaft
Kessinger Ann M.
Shah Mukund J.
LandOfFree
Hypolipidemic 1,4-benzothiazepine-1,1-dioxides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypolipidemic 1,4-benzothiazepine-1,1-dioxides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypolipidemic 1,4-benzothiazepine-1,1-dioxides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-937676